Neuraxpharm Group, a European specialty pharmaceutical company focused on the central nervous system, has expanded its operations in Southern Europe with the launch of Neuraxpharm Portugal, it was reported yesterday.
The new office will be part of the company's Southern European Region that includes Italy, Spain and now Portugal.
Javier Mercade, general manager for Italy and Spain, was named as head of the Southern Region earlier this year, which will include Spain, Italy and Portugal. The company has also named Teng Dias as commercial director of the Portugal business.
GelMEDIX completes USD13m seed financing, announces first partnership
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers